Tag: #AntimicrobialStewardship
Pharm To Exam Table – Candida glabrata Urinary Tract Infections
The following is a clinical review written by Allison Graner, UNMC College of Pharmacy PharmD candidate 2019, and supervised by Scott Bergman PharmD FIDSA, Clinical Pharmacy Coordinator of Nebraska Medicine Antimicrobial Stewardship Program What is the appropriate treatment for urinary tract infection caused by Candida glabrata? Infections caused by the fungus known as Candida, the […]
Dec 21, 2018
UNMC Infectious Diseases Fellows are Antibiotics Aware
The following was written by Dr. Raj Karnatak, 2nd year ID fellow at UNMC; a reflection of his current Antimicrobial Stewardship/Infection Control rotation: The UNMC Infectious Diseases fellowship antimicrobial stewardship and infection control rotation provides robust training for fellows in both antimicrobial stewardship and infection control. Training is well designed with education in all the […]
Nov 16, 2018
How Nebraska ASAP is Making Everyone Antibiotic Aware
The following was written by Dr. Salman Ashraf, co-Medical Director of the Nebraska Antimicrobial Stewardship Assessment & Promotion Program (ASAP): Antibiotic Resistance is one of the most urgent threats to the public health. Overuse and misuse of antibiotics allows the development of antibiotic-resistant bacteria. Unfortunately, a significant proportion of antibiotic use in various healthcare settings […]
Nov 15, 2018
Nebraska Medicine is Proud to #BeAntibioticsAware
Our Antimicrobial Stewardship Program (ASP) at Nebraska Medicine has been in place since 2004. Over the years our program has changed and improved sought to expand and improve its approach with the goal of providing extraordinary care to our patients. Rather than an overly restrictive practice, our program has we have emphasized constant regular communication […]
Nov 14, 2018
Governor Ricketts Proclaims Antibiotic Awareness Week in Nebraska
Last year, Nebraska’s Governor Pete Ricketts signed a proclamation declaring Antibiotic Awareness Week in Nebraska, and he again signed a proclamation this year, declaring November 12-18 Antibiotic Awareness Week in our state. Once again, Dr. Maureen Tierney, leader of Nebraska’s Healthcare Associated Infections Program, championed the drafting of the proclamation and received support from the Governor for […]
Nov 12, 2018
UNMC Division of Infectious Diseases – New Faculty Announcement
The Division of Infectious Diseases is pleased to announce the arrival of our newest Faculty members! Nada Fadul, MD Dr. Fadul will be supporting UNMC’s efforts on various Ryan White awards through the Specialty Care Center, where she will also serve as the Associate Medical Director. In addition, Dr. Fadul will support the General ID […]
Oct 22, 2018
An Empiric Nudge in the Right Direction
The following review was originally posted by Dr. Marcelin to the September 2018 SHEA Journal Club and featured on Medscape’s SHEA Expert Commentary earlier this month. Use of empiric antimicrobial treatment in acute care settings is often the result of the “diagnosis momentum” heuristic, wherein the antibiotics started in one location for “sepsis” are continued for several […]
Oct 9, 2018
The following was originally posted to the Controversies in Hospital Infection Prevention Blog on 9/24/18 by Dr. Marcelin. September 28, 2018 marks 90 years since Sir Alexander Fleming discovered penicillin as an effective antimicrobial which would soon save millions of lives. He warned soon afterwards that unless we used penicillin judiciously, we would see antibiotic […]
Sep 28, 2018
The Department of Pharmaceutical and Nutrition Care at Nebraska Medicine and the Division of Infectious Diseases at the University of Nebraska Medical Center (UNMC) are recruiting for a full-time clinical pharmacist to expand the Antimicrobial Stewardship Program and develop an Outpatient Parenteral Antimicrobial Therapy (OPAT) program in collaboration with a new Orthopedic Infectious Diseases service […]
Aug 27, 2018
Ceftazidime-avibactam is approved by the Food & Drug Administration (FDA) for treatment of complicated intra-abdominal and urinary tract infections, and has activity against carbapenem-resistant Enterobacteriaceae (CRE). Data regarding its real-world application and potential pitfalls is still emerging, and this review illustrates some experiences with use and emerging resistance to ceftazidime-avibactam. The authors of the first […]
Aug 15, 2018
Recent Comments